LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

LLY

1,080.21

+1.73%↑

JNJ

223.5

+0.31%↑

ABBV

217.16

+0.73%↑

UNH

377.97

+0.23%↑

MRK

114.86

-0.95%↓

Home・Aktien・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Geschlossen

1.16

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.13

Max

1.19

Schlüsselkennzahlen
By Trading Economics
Einkommen	3.5M -20M
EPS	-0.32
Angestellte	49
EBITDA	6.8M -22M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+130.17% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	6.7K 74M
Vorheriger Eröffnungskurs	1.16
Vorheriger Schlusskurs	1.16

Pliant Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Juni 2026, 23:22 UTC

Ergebnisse

Wichtige Markttreiber

Broadcom Shares Slide Despite Jump in 2Q Revenue on AI Chip Demand -- Update

3. Juni 2026, 23:09 UTC

Heiße Aktien

Stocks to Watch: Broadcom, CrowdStrike, PVH, Petco

3. Juni 2026, 20:51 UTC

Ergebnisse

Costco Reports 15% Sales Growth in May

3. Juni 2026, 20:43 UTC

Ergebnisse

Broadcom 2Q Revenue Climbs on AI Chip Demand

3. Juni 2026, 23:48 UTC

Market Talk

Nikkei May Fall Amid Renewed Concerns About Iran Conflict -- Market Talk

3. Juni 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Juni 2026, 23:35 UTC

Market Talk

Oil Futures Fall on Possible Technical Correction -- Market Talk

3. Juni 2026, 23:15 UTC

Market Talk

Ergebnisse

Five Below, Broadcom and Crowdstrike Fall Despite Solid Results -- Market Talk

3. Juni 2026, 22:08 UTC

Heiße Aktien

After-Hours Stocks to Watch: CrowdStrike, Broadcom, Five Below -- WSJ

3. Juni 2026, 21:54 UTC

Market Talk

Correction to Oil Futures Rise on Concerns About U.S.-Iran Talks Article on June 1

3. Juni 2026, 21:18 UTC

Ergebnisse

Broadcom's Non-AI Semiconductor Revenue Rose 6% in 2Q, CEO Says

3. Juni 2026, 21:15 UTC

Ergebnisse

Broadcom CEO: Google Partnership Continues to Be 'Very Substantial'

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom CEO Expects AI Semiconductor Revenue Growth to Continue in Fiscal 2028

3. Juni 2026, 21:13 UTC

Ergebnisse

Broadcom Continues to Expect AI Semiconductor Revenue of More Than $100B in 2027, CEO Says

3. Juni 2026, 21:12 UTC

Ergebnisse

Broadcom Expects AI Semiconductor Revenue of $56B This Year, CEO Says

3. Juni 2026, 21:09 UTC

Ergebnisse

Broadcom CEO: Networking Made Up Almost 40% of AI Revenue in 2Q

3. Juni 2026, 21:03 UTC

Ergebnisse

Broadcom Stock Falls After Earnings. Here's Why. -- Barrons.com

3. Juni 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3. Juni 2026, 20:43 UTC

Ergebnisse

CrowdStrike Stock Falls Despite Earnings Beat -- Barrons.com

3. Juni 2026, 20:39 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 4th Update

3. Juni 2026, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 3rd Update

3. Juni 2026, 20:35 UTC

Ergebnisse

Broadcom Stock Falls Despite Record Results -- Barrons.com

3. Juni 2026, 20:21 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- 2nd Update

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom 2Q Semiconductor Solutions Revenue $15B >AVGO

3. Juni 2026, 20:17 UTC

Ergebnisse

Broadcom Sees 3Q Semiconductor Revenue From AI $16B >AVGO

3. Juni 2026, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman's Pershing Square Set To Make $600 Million on Universal Stake -- Update

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $2.44 >AVGO

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.91 >AVGO

3. Juni 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3. Juni 2026, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $22.19B >AVGO

Peer-Vergleich

Kursveränderung

Pliant Therapeutics Inc Prognose

Kursziel

By TipRanks

130.17% Vorteil

12-Monats-Prognose

Durchschnitt 2.67 USD 130.17%

Hoch 3 USD

Tief 2 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pliant Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pliant Therapeutics Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.